# A Study of DII235 in Adults With Elevated Lipoprotein(a)

> **NCT07235046** · PHASE2 · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 200 (estimated)

## Conditions studied

- Lipoprotein Disorder

## Interventions

- **DRUG:** DII235
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT07235046
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2027-09-08
- **Final completion:** 2028-09-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07235046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07235046, "A Study of DII235 in Adults With Elevated Lipoprotein(a)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07235046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*